Actively Recruiting
AI-Guided Hematoma Aspiration vs. Conservative Treatment for Spontaneous ICH
Led by Xiaolei Chen · Updated on 2026-04-27
680
Participants Needed
1
Research Sites
312 weeks
Total Duration
On this page
Sponsors
X
Xiaolei Chen
Lead Sponsor
J
Jingzhou Central Hospital
Collaborating Sponsor
AI-Summary
What this Trial Is About
The effectiveness of traditional craniotomy in the treatment of intracerebral hemorrhage remains controversial. Minimally invasive surgery, specially, image-guided hematoma aspiration, proves to be effective and may have some advantages compared with craniotomy. This multicenter randomized controlled trial aims to evaluate and compare the clinical efficacy of two minimally invasive treatment strategies for patients with spontaneous supratentorial intracerebral hemorrhage (ICH) with moderate hematoma volume (20-50 mL): (1) AI-assisted, navigation-guided hematoma aspiration, and (2) targeted pharmacological therapy. This study is designed to address the current lack of prospective comparative evidence between advanced image-guided surgical intervention and medical management in this specific patient population. By focusing on functional recovery, hematoma resolution, and safety outcomes, this trial seeks to provide high-quality evidence to guide treatment decision-making and optimize individualized care for patients with spontaneous ICH.
CONDITIONS
Official Title
AI-Guided Hematoma Aspiration vs. Conservative Treatment for Spontaneous ICH
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Confirmed supratentorial hypertensive intracerebral hemorrhage on brain CT scan
- Hematoma volume 20-50mL
- Patients with GCS score 658
- Admitted within 24 hours of ictus
You will not qualify if you...
- Intracerebral hemorrhage caused by tumor, coagulopathy, aneurysm, or arteriovenous malformation
- Concurrent head injury or history of head injury
- Multiple intracerebral hemorrhage
- Known advanced dementia or disability before
- Severe concomitant diseases that affect life expectancy
- Severe intraventricular hemorrhage
- Pregnant women
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Chinese PLA General Hospital
Beijing, Beijing Municipality, China, 100853
Actively Recruiting
Research Team
X
Xinghua Xu, MD
CONTACT
Q
Qun Wang, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here